The company is moving its production of the GAD65 protein, the active substance in its diabetes vaccine Diamyd, from abroad to Umeå, Sweden. The new unit is around 1,000 square meters in size and contains clean rooms, laboratories and offices. Today, the unit has six employees, including proteinAlready a subscriber…